Skip to search formSkip to main contentSkip to account menu

inalimarev

Known as: vaccinia-CEA-MUC-1-TRICOM vaccine, recombinant vaccinia-CEA(D609)/MUC1(L93)/TRICOM vaccine, Vaccinia-CEA-MUC1-TRICOM Vaccine 
A cancer vaccine comprised of a recombinant vaccinia viral vector encoding the carcinoembryonic antigen (CEA), MUC-1 (mucin-1), a transmembrane… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL Therapeutic vaccines have now reached a tipping… 
2009
2009
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2008
2008
Gateways to clinical trials is a guide to the most recent trials in current literature and congresses. The data in the following…